Original Contribution Diabetes Risk Associated with Use of Olanzapine, Quetiapine, and Risperidone in Veterans Health Administration Patients with Schizophrenia
نویسندگان
چکیده
1 Department of Pharmacy Administration, College of Pharmacy, University of Illinois at Chicago, Chicago, IL. 2 Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL. 3 Department of Veterans Affairs, Pharmacy Benefits Management Strategic Healthcare Group, Hines, IL. 4 Center for Health Quality, Outcomes, and Economic Research, Veterans Health Administration, Bedford, MA. 5 Department of Health Services, School of Public Health, Boston University, Boston, MA. 6 Psychiatry Service, VA Ann Arbor Healthcare System, Ann Arbor, MI. 7 Department of Psychiatry, Medical School, University of Michigan, Ann Arbor, MI. 8 Cooperative Studies Program Coordinating Center, Edward Hines, Jr. VA Hospital, Hines, IL. 9 Center for Health Statistics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL.
منابع مشابه
Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.
To evaluate risk of new-onset type 2 diabetes associated with use of selected antipsychotic agents, the authors conducted a new-user cohort study in a national sample of US Veterans Health Administration patients with schizophrenia (and no preexisting diabetes). The authors studied 15,767 patients who initiated use of olanzapine, risperidone, quetiapine, or haloperidol in 1999-2001 after at lea...
متن کاملAssociation of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
OBJECTIVE The development of both type I and type II diabetes after initiation of some atypical neuroleptics has been reported, primarily in studies involving small series of patients. This study used administrative data from a large national sample of patients with a diagnosis of schizophrenia to compare the prevalence of diabetes mellitus in patients receiving prescriptions for atypical and t...
متن کاملIncidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
OBJECTIVE The purpose of the study was to determine the proportion of patients with schizophrenia with a stable regimen of antipsychotic monotherapy who developed diabetes or were hospitalized for ketoacidosis. METHOD Patients with schizophrenia for whom a stable regimen of antipsychotic monotherapy was consistently prescribed during any 3-month period between June 1999 and September 2000 and...
متن کاملAtypical antipsychotic agents, retinopathy, nephropathy, and cardiovascular disease.
Diabetes and atypical antipsychotic agents John Newcomer (St. Louis, MO) discussed changes in adiposity and insulin sensitivity with the atypical antipsychotic agents ziprasidone, risperidone, aripiprazole, quetiapine, clozapine, and olanzapine, addressing the diabetes risk seen during treatment. Among persons with schizophrenia, approximately half are obese, half to three-quarters smoke, 10– 1...
متن کاملClozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
BACKGROUND Numerous case reports have linked clozapine to the development of diabetes mellitus and hyperlipidemia in patients with schizophrenia. However, investigators have been unable to clearly demonstrate this association when compared with a control group receiving conventional antipsychotics. METHODS Medical and pharmacy claims from the Iowa Medicaid program were used to compare inciden...
متن کامل